Literature DB >> 22802023

[Conventional basis therapy of rheumatoid arthritis. Effects within and outside cells].

G Keyßer1.   

Abstract

Conventional disease-modifying antirheumatic drugs (DMARDs) were formerly introduced into the treatment of rheumatoid arthritis and other rheumatic disorders on an empirical basis. In many cases their mode of action is only partially understood but as a rule of thumb they act on more than one point within the cellular metabolism. Less often they exert biological effects in the extracellular space or on the cell membrane.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22802023     DOI: 10.1007/s00393-011-0878-3

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  34 in total

1.  Study of anti-inflammatory action of aurothiomalate, an inhibitor of NF-κB.

Authors:  Yu P Belsky; A N Ivanova; M G Danilets; N V Belska; A A Ligatcheva; E G Uchasova; D V Reikhart
Journal:  Bull Exp Biol Med       Date:  2011-06       Impact factor: 0.804

2.  Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties.

Authors:  F D Goldman; A L Gilman; C Hollenback; R M Kato; B A Premack; D J Rawlings
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

3.  Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.

Authors:  C Wahl; S Liptay; G Adler; R M Schmid
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

4.  Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils.

Authors:  W F Stenson; J Mehta; I Spilberg
Journal:  Biochem Pharmacol       Date:  1984-02-01       Impact factor: 5.858

5.  Induction of apoptosis in peripheral blood lymphocytes following treatment in vitro with hydroxychloroquine.

Authors:  X W Meng; J M Feller; J B Ziegler; S M Pittman; C M Ireland
Journal:  Arthritis Rheum       Date:  1997-05

6.  Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells.

Authors:  B E van den Borne; B A Dijkmans; H H de Rooij; S le Cessie; C L Verweij
Journal:  J Rheumatol       Date:  1997-01       Impact factor: 4.666

7.  The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor alpha expression in macrophages by inducing apoptosis.

Authors:  R J Rodenburg; A Ganga; P L van Lent; L B van de Putte; W J van Venrooij
Journal:  Arthritis Rheum       Date:  2000-09

Review 8.  Clinical features associated with glucocorticoid receptor polymorphisms. An overview.

Authors:  Laura Manenschijn; Erica L T van den Akker; Steven W J Lamberts; Elisabeth F C van Rossum
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

9.  Mechanism of action of hydroxychloroquine as an antirheumatic drug.

Authors:  R I Fox
Journal:  Semin Arthritis Rheum       Date:  1993-10       Impact factor: 5.532

Review 10.  The antirheumatic agents sulphasalazine and methotrexate share an anti-inflammatory mechanism.

Authors:  B N Cronstein
Journal:  Br J Rheumatol       Date:  1995-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.